Quality Chemical Industries Limited (QCIL), formerly Cipla Quality Chemical Industries Limited (CiplaQCIL) is a pharmaceutical manufacturing company, established in Uganda in 2005. The company is the largest producer of World Health Organization (WHO) pre-qualified HIV/AIDS and malaria treatments in the region. According to a 2007 published report, QCIL was the only company in Africa to manufacture triple-combination antiretroviral (ARV) drugs.[2] QCIL currently produces TLD (a combination of tenofovir, lamivudine and dolutegravir), the latest first-line treatment used to treat and prevent HIV/AIDS. QCIL also manufactures antimalarials (ACTs), including Lumartem, containing artemisinin and lumefantrine,[3] and the Hepatitis B generic medicines Texavir and Zentair.[4][5]
The company also manufactures antibacterials, anti-hypertensives, vasodilators, anti-emetics, antibiotics and antidiabetics.